Intraperitoneal and Subcutaneous Glucagon Delivery in Anaesthetized Pigs: Effects on Circulating Glucagon and Glucose Levels

APT-logo

APT member Marte Kierulf Åm har published encouraging results, summarised as follows:

Animal trials show that the hormone glucagon gives a larger increase of glucose level when it is administered into the peritoneal cavity than when it is infused in subcutaneous tissue. This can improve the glucose control in diabetes, as part of an intraperitoneal artificial pancreas.

The study is published in Scientific Reports and was performed by PhD candidate Marte Kierulf Åm and other members of the Artificial Pancreas Trondheim research group (APT) at NTNU, as part of our Double Intraperitoneal Artificial Pancreas project. 

Forfatter

Sven Magnus Carlsen

E-post: sven.carlsen@ntnu.no
Tlf: 91769528

Profil

Anders Lyngvi Fougner

E-post: anders.fougner@ntnu.no
Tlf: 97158863

Profil

Sverre Christian Christiansen

E-post: sverre.christiansen@ntnu.no

Profil

Marte Kierulf Åm

E-post: marte.k.am@ntnu.no

Profil

Ilze Dirnena-Fusini

E-post: ilze.dirnena-fusini@ntnu.no

Profil

Tilknyttet prosjekt
Tema
Helse Forskning

Publisert: 22. Oct 2020 - kl. 13:52
Sist oppdatert: 22. Oct 2020 - kl. 13:53